151 related articles for article (PubMed ID: 10845659)
1. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.
Roozendaal C; de Jong MA; van den Berg AP; van Wijk RT; Limburg PC; Kallenberg CG
J Hepatol; 2000 May; 32(5):734-41. PubMed ID: 10845659
[TBL] [Abstract][Full Text] [Related]
2. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.
Pang SY; Dai YM; Zhang RZ; Chen YH; Peng XF; Fu J; Chen ZR; Liu YF; Yang LY; Wen Z; Yu JK; Liu HY
World J Gastroenterol; 2018 Jan; 24(3):387-396. PubMed ID: 29391761
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features.
Roozendaal C; Van Milligen de Wit AW; Haagsma EB; Horst G; Schwarze C; Peter HH; Kleibeuker JH; Tervaert JW; Limburg PC; Kallenberg CG
Am J Med; 1998 Nov; 105(5):393-9. PubMed ID: 9831423
[TBL] [Abstract][Full Text] [Related]
6. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
7. Does analysis of the antigenic specificities of anti-neutrophil cytoplasmic antibodies contribute to their clinical significance in the inflammatory bowel diseases?
Roozendaal C; Pogány K; Horst G; Jagt TG; Kleibeuker JH; Nelis GF; Limburg PC; Kallenberg CG
Scand J Gastroenterol; 1999 Nov; 34(11):1123-31. PubMed ID: 10582764
[TBL] [Abstract][Full Text] [Related]
8. Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases.
Roozendaal C; Kallenberg CG
Hepatogastroenterology; 1999; 46(30):3034-40. PubMed ID: 10626156
[TBL] [Abstract][Full Text] [Related]
9. What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease?
De Riva V; Celadin M; Pittoni M; Plebani M; Angeli P
Liver Int; 2009 Jul; 29(6):865-70. PubMed ID: 19453948
[TBL] [Abstract][Full Text] [Related]
10. Antilactoferrin antibodies in autoimmune liver disease.
Muratori L; Muratori P; Zauli D; Grassi A; Pappas G; Rodrigo L; Cassani F; Lenzi M; Bianchi FB
Clin Exp Immunol; 2001 Jun; 124(3):470-3. PubMed ID: 11472410
[TBL] [Abstract][Full Text] [Related]
11. IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis.
Schwarze C; Terjung B; Lilienweiss P; Beuers U; Herzog V; Sauerbruch T; Spengler U
Clin Exp Immunol; 2003 Aug; 133(2):283-9. PubMed ID: 12869036
[TBL] [Abstract][Full Text] [Related]
12. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis.
Sobajima J; Ozaki S; Uesugi H; Osakada F; Inoue M; Fukuda Y; Shirakawa H; Yoshida M; Rokuhara A; Imai H; Kiyosawa K; Nakao K
Gut; 1999 Jun; 44(6):867-73. PubMed ID: 10323891
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
14. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC).
Stinton LM; Bentow C; Mahler M; Norman GL; Eksteen B; Mason AL; Kaplan GG; Lindkvist B; Hirschfield GM; Milkiewicz P; Cheung A; Janssen HL; Fritzler MJ
PLoS One; 2014; 9(11):e112877. PubMed ID: 25397578
[TBL] [Abstract][Full Text] [Related]
15. Actin is a target antigen of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune hepatitis type-1.
Orth T; Gerken G; Kellner R; Meyer zum Büschenfelde KH; Mayet WJ
J Hepatol; 1997 Jan; 26(1):37-47. PubMed ID: 9148020
[TBL] [Abstract][Full Text] [Related]
16. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
[TBL] [Abstract][Full Text] [Related]
17. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
Bansi D; Chapman R; Fleming K
J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.
Papp M; Sipeki N; Vitalis Z; Tornai T; Altorjay I; Tornai I; Udvardy M; Fechner K; Jacobsen S; Teegen B; Sumegi A; Veres G; Lakatos PL; Kappelmayer J; Antal-Szalmas P
J Hepatol; 2013 Sep; 59(3):457-66. PubMed ID: 23639483
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
[TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibodies (ANCA) specific for one or several antigens: useful markers for subtypes of ulcerative colitis and associated primary sclerosing cholangitis.
Dobric S; Popovic D; Nikolic M; Andrejevic S; Spuran M; Bonaci-Nikolic B
Clin Chem Lab Med; 2011 Nov; 50(3):503-9. PubMed ID: 22107137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
